• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波生坦显著减轻弥漫性皮肤系统性硬皮病伴多发性指端溃疡和坏疽患者的大血管受累。

Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.

机构信息

Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

Mod Rheumatol. 2011 Oct;21(5):548-52. doi: 10.1007/s10165-011-0436-5. Epub 2011 Mar 10.

DOI:10.1007/s10165-011-0436-5
PMID:21547701
Abstract

Systemic sclerosis (SSc) is characterized by vascular injuries, and bosentan has recently been proved to be efficacious for the prevention of new digital ulcers in SSc. We herein report a case of SSc in a patient with refractory digital ulcers and gangrene treated with bosentan. Stenosis of the ulnar artery, evaluated by magnetic resonance angiography, was attenuated by the bosentan treatment, suggesting that bosentan exerts a reverse remodeling effect against the pathological organic changes of arteries in SSc.

摘要

系统性硬化症(SSc)的特征是血管损伤,波生坦最近已被证明可有效预防 SSc 中新发的手指溃疡。我们在此报告一例使用波生坦治疗难治性手指溃疡和坏疽的 SSc 患者。磁共振血管造影评估发现,尺动脉狭窄得到了波生坦治疗的缓解,这表明波生坦对 SSc 中动脉的病理性组织改变具有逆转重构作用。

相似文献

1
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.波生坦显著减轻弥漫性皮肤系统性硬皮病伴多发性指端溃疡和坏疽患者的大血管受累。
Mod Rheumatol. 2011 Oct;21(5):548-52. doi: 10.1007/s10165-011-0436-5. Epub 2011 Mar 10.
2
Bosentan for digital ulcers in patients with systemic sclerosis.波生坦治疗系统性硬化症患者的手指溃疡。
J Dermatol. 2012 Jan;39(1):48-51. doi: 10.1111/j.1346-8138.2011.01299.x. Epub 2011 Sep 28.
3
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.系统性硬化症中的指端溃疡:通过口服内皮素受体拮抗剂波生坦治疗进行预防
Arthritis Rheum. 2004 Dec;50(12):3985-93. doi: 10.1002/art.20676.
4
Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.局限性和弥漫性皮肤系统性硬化症中数字血管病变的临床负担
Ann Rheum Dis. 2008 Jan;67(1):120-3. doi: 10.1136/ard.2007.072686. Epub 2007 Jul 27.
5
Bosentan as a rescue therapy in scleroderma refractory digital ulcers.波生坦作为硬皮病难治性指端溃疡的挽救治疗方法。
Arch Dermatol. 2007 Jan;143(1):125-6. doi: 10.1001/archderm.143.1.125.
6
Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus.波生坦成功治疗一名系统性红斑狼疮患者的难治性指端溃疡。
J Dermatol. 2008 Jul;35(7):447-51. doi: 10.1111/j.1346-8138.2008.00500.x.
7
Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.系统性硬化症患者四肢血管变化的动脉造影评估。
Br J Dermatol. 2006 Dec;155(6):1159-64. doi: 10.1111/j.1365-2133.2006.07475.x.
8
Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.波生坦治疗系统性硬化症患者指端溃疡:一项为期3年的前瞻性随访研究。
J Rheumatol. 2009 Jul;36(7):1550-2. doi: 10.3899/jrheum.080992.
9
[Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].系统性硬化症中的指端溃疡:一项回顾性医疗服务研究,分析波生坦及其他血管活性疗法的治疗情况
Z Rheumatol. 2017 Apr;76(3):228-237. doi: 10.1007/s00393-016-0177-0.
10
[Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].波生坦治疗系统性硬化症患者的活动性指端溃疡
Presse Med. 2006 Apr;35(4 Pt 1):587-92. doi: 10.1016/s0755-4982(06)74645-0.

引用本文的文献

1
What can we learn from -deficient mice, new animal models of systemic sclerosis?我们能从系统性硬化症的新动物模型——缺陷小鼠身上学到什么?
J Scleroderma Relat Disord. 2018 Feb;3(1):6-13. doi: 10.1177/2397198318758221. Epub 2018 Apr 4.
2
Vasculopathy in scleroderma.硬皮病中的血管病变
Semin Immunopathol. 2015 Sep;37(5):489-500. doi: 10.1007/s00281-015-0505-5. Epub 2015 Jul 8.
3
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
内皮细胞特异性 Fli-1 敲除小鼠中内皮素受体阻断通过增加 Fli-1 DNA 结合能力改善血管脆弱性。
Arthritis Rheumatol. 2015 May;67(5):1335-44. doi: 10.1002/art.39062.
4
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.回顾性分析波生坦或伊洛前列素治疗系统性硬皮病患者中心性面毛细血管扩张症的频率。
Eur J Med Res. 2014 Jan 10;19(1):2. doi: 10.1186/2047-783X-19-2.
5
Management of Raynaud's phenomenon and digital ischemia.雷诺现象和指(趾)缺血的管理。
Curr Rheumatol Rep. 2013 Jan;15(1):303. doi: 10.1007/s11926-012-0303-1.